or
forgot password
  • cancer clinical trials in alabama

  • Integrated Smoking Cessation Treatment for Low Income Community Corrections
    UAB Substance Abuse
    Birmingham, Alabama 35209
    Smoking Cessation
    Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
    Clinical Research Associates

    Trial Locations
    Clinical Research Associates
    Achieve Clinical Research, LLC
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
    Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Cervical Cancer
    Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    University of South Alabama Mitchell Cancer Institute
    Providence Hospital
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
    University of Alabama at Birbingham School of Medicine
    South Birmingham, Alabama 35294
    Glioblastoma Multiforme
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    A Safety Study in Patients With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama 35294
    Advanced Solid Tumors
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Urology Centers of Alabama, PC
    Birmingham, Alabama 35209
    Prostatic Neoplasms
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Urology Centers Of Alabama

    Trial Locations
    Urology Centers Of Alabama
    Medical Affiliated Research Center, Inc.
    James Gordon McMurray, MD
    Mobile Ob-Gyn, P.C.
    Montgomery Women's Health Associates, P.C.
    Scottsboro Quick Care Clinic
    Achieve Clinical Research, LLC
    Overactive Bladder
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Birmingham Hematology and Oncology Associates, LLC
    Birmingham, Alabama 35235
    Advanced Prostate Cancer, Prostatic Neoplasms
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Fungal Infection, Leukemia, Neutropenia
    Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
    University of Alabama at Birmingham (UAB)
    Birmingham, Alabama 35233
    Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer, Metastatic Breast Cancer
    Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
    Investigational Site Number 840004
    Muscle Shoals, Alabama 35661
    Prostate Cancer
    Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS I
    University of Alabama
    Birmingham, Alabama
    Lung Cancer
    A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, NK-cell, Lymphoma, T-cell
    Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer, Advanced Solid Tumors
    IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

    Birmingham, Alabama 35294
    Prostate Cancer, Prostatic Neoplasm
    Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Metastatic Breast Cancer
    Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Solid Tumor
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Recurrent Neuroblastoma
    MaxAn Post Market Surveillance Validation
    Montgomery Spine Center
    Montgomery, Alabama 36116
    DDD, Deformity, Tumor, Fracture
    Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1
    University of Alabama at Birmingham - 1917 Research Clinic

    Trial Locations
    University of Alabama at Birmingham - 1917 Research Clinic
    Health Services Center
    HIV-1
    Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    The Kirklin Clinic at Acton Road
    Breast Cancer
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia
    Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
    GTx Investigative Site
    Birmingham, Alabama 35211
    Muscle Wasting, Non Small Cell Lung Cancer
    Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
    GTx Investigative Site
    Birmingham, Alabama 35211
    Muscle Wasting, Non-Small Cell Lung Cancer
    ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Non-Small Cell Lung Cancer (NSCLC)
    Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

    Birmingham, Alabama 35294
    Pain, Advanced Cancer
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    University of South Alabama
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Bone Mineral Density in HIV+ Patients
    UAB
    Birmingham, Alabama 35294
    Osteoporosis
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    University of South Alabama / Mitchell Cancer Institute Univ South Alabama
    Mobile, Alabama 36688
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Recurrent Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma